During the COVID-19 pandemic, Switzerland, like many other countries, relied on contact tracing to identify people likely to have been contaminated by an infected acquaintance.
Formycon resolves on cash capital increase of EUR 82.84 million – all new shares were subscribed by Gedeon Richter as new strategic investor – Biotech Investments
Formycon AG / Key word(s): Corporate Action/Capital Increase Formycon resolves on cash capital increase of EUR 82.84 million – all new shares were subscribed by
January 30, 2024